Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: (−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Fig. 5

Effects of compound 3, cDDP, or a combination of the two drugs on the EGFR signaling pathway in NCI-H441 cells. a NCI-H441 cells treated with various concentrations of compound 3 (0, 50, 100, or 150 μM). b NCI-H441 cells treated with compound 3 (50 μM) and cDDP (12 μM) in combination or individually. The expression levels of the proteins were determined by western blotting after 12 h with β-tubulin as the loading control

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us